NCT05109832View on ClinicalTrials.gov

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 9, 2021

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions
Solid Tumor
Interventions
DRUG

14C-IMP4297

14C marked IMP4297

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
lead

Impact Therapeutics, Inc.

INDUSTRY

NCT05109832 - A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects | Biotech Hunter | Biotech Hunter